Note payable to DIRECTV
Pfizer Note payable to DIRECTV decreased by 4.4% to $18.65B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.4%, from $19.72B to $18.65B. Over 5 years (FY 2020 to FY 2025), Note payable to DIRECTV shows an upward trend with a 8.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase indicates higher short-term debt obligations to related parties, while a decrease reflects repayment or settlement of these specific liabilities. High levels may suggest reliance on related-party financing for working capital needs.
Detailed definition
This represents a short-term financial obligation owed to a related party, specifically categorized as a current liabili...
Peer comparison
Comparable to other 'Notes Payable to Related Parties' or 'Due to Affiliates' found in the current liabilities section of peer company balance sheets.
note_payable_directvHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.22B | $20.69B | $24.94B | $24.58B | $23.82B | $19.65B | $22.57B | $20.26B | $16.08B | $16.78B | $20.54B | $18.79B | $16.41B | $19.92B | $19.72B | $20.02B | $18.58B | $19.51B | $18.65B |
| QoQ Change | — | +20.2% | +20.5% | -1.4% | -3.1% | -17.5% | +14.9% | -10.2% | -20.6% | +4.3% | +22.4% | -8.5% | -12.7% | +21.4% | -1.0% | +1.5% | -7.2% | +5.0% | -4.4% |
| YoY Change | — | — | — | — | +38.3% | -5.0% | -9.5% | -17.6% | -32.5% | -14.6% | -9.0% | -7.2% | +2.1% | +18.7% | -4.0% | +6.5% | +13.2% | -2.0% | -5.4% |
Note payable to DIRECTV at Other Companies
Frequently Asked Questions
- What is Pfizer's note payable to directv?
- Pfizer (PFE) reported note payable to directv of $18.65B in Q4 2025.
- How has Pfizer's note payable to directv changed year-over-year?
- Pfizer's note payable to directv decreased by 5.4% year-over-year, from $19.72B to $18.65B.
- What is the long-term trend for Pfizer's note payable to directv?
- Over 5 years (2020 to 2025), Pfizer's note payable to directv has grown at a 8.1% compound annual growth rate (CAGR), from $12.64B to $18.65B.
- What does note payable to directv mean?
- A short-term debt obligation owed to a related business entity.